A detailed history of American Century Companies Inc transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, American Century Companies Inc holds 226,057 shares of AMRX stock, worth $1.44 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
226,057
Previous 174,429 29.6%
Holding current value
$1.44 Million
Previous $1.06 Million 29.4%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$5.24 - $6.34 $270,530 - $327,321
51,628 Added 29.6%
226,057 $1.37 Million
Q4 2023

Feb 13, 2024

BUY
$3.36 - $6.21 $586,081 - $1.08 Million
174,429 New
174,429 $1.06 Million
Q3 2023

Nov 13, 2023

BUY
$2.76 - $4.59 $127,583 - $212,177
46,226 Added 117.88%
85,439 $360,000
Q2 2023

Aug 14, 2023

BUY
$1.33 - $3.1 $23,272 - $54,243
17,498 Added 80.58%
39,213 $121,000
Q1 2023

May 11, 2023

BUY
$1.27 - $2.7 $8,317 - $17,682
6,549 Added 43.18%
21,715 $30,000
Q4 2022

Feb 13, 2023

BUY
$1.96 - $2.61 $29,725 - $39,583
15,166 New
15,166 $30,000
Q4 2020

Feb 12, 2021

SELL
$3.95 - $5.42 $255,592 - $350,711
-64,707 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$3.54 - $5.27 $920 - $1,370
260 Added 0.4%
64,707 $251,000
Q2 2020

Aug 13, 2020

SELL
$2.87 - $5.46 $193,475 - $368,074
-67,413 Reduced 51.12%
64,447 $307,000
Q1 2020

May 14, 2020

BUY
$2.46 - $5.35 $324,375 - $705,451
131,860 New
131,860 $459,000
Q2 2019

Aug 14, 2019

SELL
$6.44 - $14.29 $335,788 - $745,094
-52,141 Closed
0 $0
Q1 2019

May 14, 2019

SELL
$11.87 - $14.84 $34,423 - $43,036
-2,900 Reduced 5.27%
52,141 $0
Q4 2018

Feb 13, 2019

SELL
$13.09 - $21.49 $61,640 - $101,196
-4,709 Reduced 7.88%
55,041 $745,000
Q3 2018

Nov 02, 2018

BUY
$16.4 - $24.27 $979,899 - $1.45 Million
59,750 New
59,750 $1.33 Million

Others Institutions Holding AMRX

About Amneal Pharmaceuticals, Inc.


  • Ticker AMRX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 151,408,992
  • Market Cap $961M
  • Description
  • Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...
More about AMRX
Track This Portfolio

Track American Century Companies Inc Portfolio

Follow American Century Companies Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.